# Patent

## Title
Heat-dissipating compositions comprising estolide compounds

## Abstract

Provided herein are dielectric fluids comprising at least one estolide compound of formula:




in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 1; R1, independently for each occurrence, is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R3 and R4, independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. Also provided herein are uses of dielectric fluids and electrical devices such as transformers that comprise a dielectric fluid comprising at least one estolide compound.

## Background
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 13/407,402, filed Feb. 28, 2012, now U.S. Pat. No. 8,268,199, which claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61/498,499, filed Jun. 17, 2011, and U.S. Provisional Patent Application No. 61/548,613, filed Oct. 18, 2011, which are incorporated herein by reference in their entireties for all purposes.


FIELD
The present disclosure relates to dielectric compositions comprising estolide compounds and electrical devices containing the same.
BACKGROUND
Dielectric fluid compositions used in electrical distribution and power equipment can act as an electrical insulating medium that can transport generated heat away from the equipment, i.e., act as a cooling medium. When used in a transformer, for example, dielectric fluids can transport heat from the windings and core of the transformer or connected circuits to cooling surfaces.
SUMMARY
Described herein are dielectric fluids comprising at least one estolide compound, and methods of making and using the same.
In certain embodiments, the dielectric fluid comprises at least one estolide compound of Formula I:




wherein
x is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
y is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
n is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12;
R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
wherein each fatty acid chain residue of said at least one compound is independently optionally substituted.
In certain embodiments, the dielectric fluid comprises at least one estolide compound of Formula II:




wherein
m is an integer equal to or greater than 1;
n is an integer equal to or greater than 0;
R1, independently for each occurrence, is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R3 and R4, independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched.
In certain embodiments, the dielectric fluid comprises at least one estolide compound of Formula III:




wherein
x is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
y is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
n is an integer equal to or greater than 0;
R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
wherein each fatty acid chain residue of said at least one compound is independently optionally substituted.
In certain embodiments, dielectric fluid is contained in an electrical device, wherein the dielectric fluid comprises at least one compound of Formula I, II, or III.


DETAILED DESCRIPTION
“Dielectric fluid,” as used herein, refers to a fluid that can sustain a static electric field and act as an electrical insulator. Exemplary dielectric fluids include, but are not limited to, fire-resistant and/or non-flammable fluids. Exemplary dielectric fluids can be used in, but are not limited to use in, electrical distribution and power equipment, including, for example, but not limited to, transformers, capacitors, switching gear and electric cables.
The use of dielectric fluids, compounds, and/or compositions may result in the dispersion of such fluids, compounds, and/or compositions in the environment. Petroleum base oils used in common dielectric compositions, as well as additives, are typically non-biodegradable and can be toxic. The present disclosure provides for the preparation and use of dielectric fluids comprising partially or fully bio-degradable base oils, including base oils comprising one or more estolides.
In certain embodiments, the dielectric fluids and/or compositions comprising one or more estolides are partially or fully biodegradable and thereby pose diminished risk to the environment. In certain embodiments, the dielectric fluids and/or compositions meet guidelines set for by the Organization for Economic Cooperation and Development (OECD) for degradation and accumulation testing. The OECD has indicated that several tests may be used to determine the “ready biodegradability” of organic chemicals. Aerobic ready biodegradability by OECD 301 D measures the mineralization of the test sample to CO2 in closed aerobic microcosms that simulate an aerobic aquatic environment, with microorganisms seeded from a waste-water treatment plant. OECD 301D is considered representative of most aerobic environments that are likely to receive waste materials. Aerobic “ultimate biodegradability” can be determined by OECD 302D. Under OECD 302D, microorganisms are pre-acclimated to biodegradation of the test material during a pre-incubation period, then incubated in sealed vessels with relatively high concentrations of microorganisms and enriched mineral salts medium. OECD 302D ultimately determines whether the test materials are completely biodegradable, albeit under less stringent conditions than “ready biodegradability” assays.
In certain embodiments, the dielectric fluids and/or compositions comprising one or more estolides may meet specified standards or possess characteristics including, but not limited to, one or more selected from: color, maximum; fire point; flash point; pour point; relative density; viscosity; dielectric breakdown voltage at 60 Hz; dielectric breakdown voltage under impulse conditions; dissipation factor (or power factor) at 60 Hz; gassing tendency; presence of corrosive sulfur; neutralization number; PCB content; and water content.
As used in the present specification, the following words, phrases and symbols are generally intended to have the meanings as set forth below, except to the extent that the context in which they are used indicates otherwise. The following abbreviations and terms have the indicated meanings throughout:
A dash (“-”) that is not between two letters or symbols is used to indicate a point of attachment for a substituent. For example, —C(O)NH2 is attached through the carbon atom.
“Alkoxy” by itself or as part of another substituent refers to a radical —OR31 where R31 is alkyl, cycloalkyl, cycloalkylalkyl, aryl, or arylalkyl, which can be substituted, as defined herein. In some embodiments, alkoxy groups have from 1 to 8 carbon atoms. In some embodiments, alkoxy groups have 1, 2, 3, 4, 5, 6, 7, or 8 carbon atoms. Examples of alkoxy groups include, but are not limited to, methoxy, ethoxy, propoxy, butoxy, cyclohexyloxy, and the like.
“Alkyl” by itself or as part of another substituent refers to a saturated or unsaturated, branched, or straight-chain monovalent hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene, or alkyne. Examples of alkyl groups include, but are not limited to, methyl; ethyls such as ethanyl, ethenyl, and ethynyl; propyls such as propan-1-yl, propan-2-yl, prop-1-en-1-yl, prop-1-en-2-yl, prop-2-en-1-yl (allyl), prop-1-yn-1-yl, prop-2-yn-1-yl, etc.; butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl, 2-methyl-propan-2-yl, but-1-en-1-yl, but-1-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en-2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, but-1-yn-1-yl, but-1-yn-3-yl, but-3-yn-1-yl, etc.; and the like.
Unless otherwise indicated, the term “alkyl” is specifically intended to include groups having any degree or level of saturation, i.e., groups having exclusively single carbon-carbon bonds, groups having one or more double carbon-carbon bonds, groups having one or more triple carbon-carbon bonds, and groups having mixtures of single, double, and triple carbon-carbon bonds. Where a specific level of saturation is intended, the terms “alkanyl,” “alkenyl,” and “alkynyl” are used. In certain embodiments, an alkyl group comprises from 1 to 40 carbon atoms, in certain embodiments, from 1 to 22 or 1 to 18 carbon atoms, in certain embodiments, from 1 to 16 or 1 to 8 carbon atoms, and in certain embodiments from 1 to 6 or 1 to 3 carbon atoms. In certain embodiments, an alkyl group comprises from 8 to 22 carbon atoms, in certain embodiments, from 8 to 18 or 8 to 16. In some embodiments, the alkyl group comprises from 3 to 20 or 7 to 17 carbons. In some embodiments, the alkyl group comprises 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22 carbon atoms.
“Aryl” by itself or as part of another substituent refers to a monovalent aromatic hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of a parent aromatic ring system. Aryl encompasses 5- and 6-membered carbocyclic aromatic rings, for example, benzene; bicyclic ring systems wherein at least one ring is carbocyclic and aromatic, for example, naphthalene, indane, and tetralin; and tricyclic ring systems wherein at least one ring is carbocyclic and aromatic, for example, fluorene. Aryl encompasses multiple ring systems having at least one carbocyclic aromatic ring fused to at least one carbocyclic aromatic ring, cycloalkyl ring, or heterocycloalkyl ring. For example, aryl includes 5- and 6-membered carbocyclic aromatic rings fused to a 5- to 7-membered non-aromatic heterocycloalkyl ring containing one or more heteroatoms chosen from N, O, and S. For such fused, bicyclic ring systems wherein only one of the rings is a carbocyclic aromatic ring, the point of attachment may be at the carbocyclic aromatic ring or the heterocycloalkyl ring. Examples of aryl groups include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexalene, as-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene, and the like. In certain embodiments, an aryl group can comprise from 5 to 20 carbon atoms, and in certain embodiments, from 5 to 12 carbon atoms. In certain embodiments, an aryl group can comprise 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 carbon atoms. Aryl, however, does not encompass or overlap in any way with heteroaryl, separately defined herein. Hence, a multiple ring system in which one or more carbocyclic aromatic rings is fused to a heterocycloalkyl aromatic ring, is heteroaryl, not aryl, as defined herein.
“Arylalkyl” by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with an aryl group. Examples of arylalkyl groups include, but are not limited to, benzyl, 2-phenylethan-1-yl, 2-phenylethen-1-yl, naphthylmethyl, 2-naphthylethan-1-yl, 2-naphthylethen-1-yl, naphthobenzyl, 2-naphthophenylethan-1-yl, and the like. Where specific alkyl moieties are intended, the nomenclature arylalkanyl, arylalkenyl, or arylalkynyl is used. In certain embodiments, an arylalkyl group is C7-30 arylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the arylalkyl group is C1-10 and the aryl moiety is C6-20, and in certain embodiments, an arylalkyl group is C7-20 arylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the arylalkyl group is C1-8 and the aryl moiety is C6-12.
Estolide “base oil” and “base stock”, unless otherwise indicated, refer to any composition comprising one or more estolide compounds. It should be understood that an estolide “base oil” or “base stock” is not limited to compositions for a particular use, and may generally refer to compositions comprising one or more estolides, including mixtures of estolides. Estolide base oils and base stocks can also include compounds other than estolides.
“Compounds” refers to compounds encompassed by structural Formula I, II, and III herein and includes any specific compounds within the formula whose structure is disclosed herein. Compounds may be identified either by their chemical structure and/or chemical name. When the chemical structure and chemical name conflict, the chemical structure is determinative of the identity of the compound. The compounds described herein may contain one or more chiral centers and/or double bonds and therefore may exist as stereoisomers such as double-bond isomers (i.e., geometric isomers), enantiomers, or diastereomers. Accordingly, any chemical structures within the scope of the specification depicted, in whole or in part, with a relative configuration encompass all possible enantiomers and stereoisomers of the illustrated compounds including the stereoisomerically pure form (e.g., geometrically pure, enantiomerically pure, or diastereomerically pure) and enantiomeric and stereoisomeric mixtures. Enantiomeric and stereoisomeric mixtures may be resolved into their component enantiomers or stereoisomers using separation techniques or chiral synthesis techniques well known to the skilled artisan.
For the purposes of the present disclosure, “chiral compounds” are compounds having at least one center of chirality (i.e. at least one asymmetric atom, in particular at least one asymmetric C atom), having an axis of chirality, a plane of chirality or a screw structure. “Achiral compounds” are compounds which are not chiral.
Compounds of Formula I, II, and III include, but are not limited to, optical isomers of compounds of Formula I, II, and III, racemates thereof, and other mixtures thereof. In such embodiments, the single enantiomers or diastereomers, i.e., optically active forms, can be obtained by asymmetric synthesis or by resolution of the racemates. Resolution of the racemates may be accomplished by, for example, chromatography, using, for example a chiral high-pressure liquid chromatography (HPLC) column. However; unless otherwise stated, it should be assumed that Formula I, II, and III cover all asymmetric variants of the compounds described herein, including isomers, racemates, enantiomers, diastereomers, and other mixtures thereof. In addition, compounds of Formula I, II and III include Z- and E-forms (e.g., cis- and trans-forms) of compounds with double bonds. The compounds of Formula I, II, and III may also exist in several tautomeric forms including the enol form, the keto form, and mixtures thereof. Accordingly, the chemical structures depicted herein encompass all possible tautomeric forms of the illustrated compounds.
“Cycloalkyl” by itself or as part of another substituent refers to a saturated or unsaturated cyclic alkyl radical. Where a specific level of saturation is intended, the nomenclature“cycloalkanyl” or “cycloalkenyl” is used. Examples of cycloalkyl groups include, but are not limited to, groups derived from cyclopropane, cyclobutane, cyclopentane, cyclohexane, and the like. In certain embodiments, a cycloalkyl group is C3-15 cycloalkyl, and in certain embodiments, C3-12 cycloalkyl or C5-12 cycloalkyl. In certain embodiments, a cycloalkyl group is a C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, or C15 cycloalkyl.
“Cycloalkylalkyl” by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with a cycloalkyl group. Where specific alkyl moieties are intended, the nomenclature cycloalkylalkanyl, cycloalkylalkenyl, or cycloalkylalkynyl is used. In certain embodiments, a cycloalkylalkyl group is C7-30 cycloalkylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the cycloalkylalkyl group is C1-10 and the cycloalkyl moiety is C6-20, and in certain embodiments, a cycloalkylalkyl group is C7-20 cycloalkylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the cycloalkylalkyl group is C1-8 and the cycloalkyl moiety is C4-20 or C6-12.
“Halogen” refers to a fluoro, chloro, bromo, or iodo group.
“Heteroaryl” by itself or as part of another substituent refers to a monovalent heteroaromatic radical derived by the removal of one hydrogen atom from a single atom of a parent heteroaromatic ring system. Heteroaryl encompasses multiple ring systems having at least one aromatic ring fused to at least one other ring, which can be aromatic or non-aromatic in which at least one ring atom is a heteroatom. Heteroaryl encompasses 5- to 12-membered aromatic, such as 5- to 7-membered, monocyclic rings containing one or more, for example, from 1 to 4, or in certain embodiments, from 1 to 3, heteroatoms chosen from N, O, and S, with the remaining ring atoms being carbon; and bicyclic heterocycloalkyl rings containing one or more, for example, from 1 to 4, or in certain embodiments, from 1 to 3, heteroatoms chosen from N, O, and S, with the remaining ring atoms being carbon and wherein at least one heteroatom is present in an aromatic ring. For example, heteroaryl includes a 5- to 7-membered heterocycloalkyl, aromatic ring fused to a 5- to 7-membered cycloalkyl ring. For such fused, bicyclic heteroaryl ring systems wherein only one of the rings contains one or more heteroatoms, the point of attachment may be at the heteroaromatic ring or the cycloalkyl ring. In certain embodiments, when the total number of N, S, and O atoms in the heteroaryl group exceeds one, the heteroatoms are not adjacent to one another. In certain embodiments, the total number of N, S, and O atoms in the heteroaryl group is not more than two. In certain embodiments, the total number of N, S, and O atoms in the aromatic heterocycle is not more than one. Heteroaryl does not encompass or overlap with aryl as defined herein.
Examples of heteroaryl groups include, but are not limited to, groups derived from acridine, arsindole, carbazole, β-carboline, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, thiophene, triazole, xanthene, and the like. In certain embodiments, a heteroaryl group is from 5- to 20-membered heteroaryl, and in certain embodiments from 5- to 12-membered heteroaryl or from 5- to 10-membered heteroaryl. In certain embodiments, a heteroaryl group is a 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-, 13-, 14-, 15-, 16-, 17-, 18-, 19-, or 20-membered heteroaryl. In certain embodiments heteroaryl groups are those derived from thiophene, pyrrole, benzothiophene, benzofuran, indole, pyridine, quinoline, imidazole, oxazole, and pyrazine.
“Heteroarylalkyl” by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with a heteroaryl group. Where specific alkyl moieties are intended, the nomenclature heteroarylalkanyl, heteroarylalkenyl, or heteroarylalkynyl is used. In certain embodiments, a heteroarylalkyl group is a 6- to 30-membered heteroarylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the heteroarylalkyl is 1- to 10-membered and the heteroaryl moiety is a 5- to 20-membered heteroaryl, and in certain embodiments, 6- to 20-membered heteroarylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the heteroarylalkyl is 1- to 8-membered and the heteroaryl moiety is a 5- to 12-membered heteroaryl.
“Heterocycloalkyl” by itself or as part of another substituent refers to a partially saturated or unsaturated cyclic alkyl radical in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Examples of heteroatoms to replace the carbon atom(s) include, but are not limited to, N, P, O, S, Si, etc. Where a specific level of saturation is intended, the nomenclature “heterocycloalkanyl” or “heterocycloalkenyl” is used. Examples of heterocycloalkyl groups include, but are not limited to, groups derived from epoxides, azirines, thiiranes, imidazolidine, morpholine, piperazine, piperidine, pyrazolidine, pyrrolidine, quinuclidine, and the like.
“Heterocycloalkylalkyl” by itself or as part of another substituent refers to an acyclic alkyl radical in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with a heterocyCloalkyl group. Where specific alkyl moieties are intended, the nomenclature heterocycloalkylalkanyl, heterocycloalkylalkenyl, or heterocycloalkylalkynyl is used. In certain embodiments, a heterocycloalkylalkyl group is a 6- to 30-membered heterocycloalkylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the heterocycloalkylalkyl is 1- to 10-membered and the heterocycloalkyl moiety is a 5- to 20-membered heterocycloalkyl, and in certain embodiments, 6- to 20-membered heterocycloalkylalkyl, e.g., the alkanyl, alkenyl, or alkynyl moiety of the heterocycloalkylalkyl is 1- to 8-membered and the heterocycloalkyl moiety is a 5- to 12-membered heterocycloalkyl.
“Mixture” refers to a collection of molecules or chemical substances. Each component in a mixture can be independently varied. A mixture may contain, or consist essentially of, two or more substances intermingled with or without a constant percentage composition, wherein each component may or may not retain its essential original properties, and where molecular phase mixing may or may not occur. In mixtures, the components making up the mixture may or may not remain distinguishable from each other by virtue of their chemical structure.
“Parent aromatic ring system” refers to an unsaturated cyclic or polycyclic ring system having a conjugated π (pi) electron system. Included within the definition of “parent aromatic ring system” are fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, fluorene, indane, indene, phenalene, etc. Examples of parent aromatic ring systems include, but are not limited to, aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexalene, as-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene, and the like.
“Parent heteroaromatic ring system” refers to a parent aromatic ring system in which one or more carbon atoms (and any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Examples of heteroatoms to replace the carbon atoms include, but are not limited to, N, P, O, S, Si, etc. Specifically included within the definition of “parent heteroaromatic ring systems” are fused ring systems in which one or more of the rings are aromatic and one or more of the rings are saturated or unsaturated, such as, for example, arsindole, benzodioxan, benzofuran, chromane, chromene, indole, indoline, xanthene, etc. Examples of parent heteroaromatic ring systems include, but are not limited to, arsindole, carbazole, β-carboline, chromane, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, thiophene, triazole, xanthene, and the like.
“Substituted” refers to a group in which one or more hydrogen atoms are independently replaced with the same or different substituent(s). Examples of substituents include, but are not limited to, —R64, —R60, —O−, —OH, ═O, —O—R60, —SR60, —S−, ═S, —NR60R61, ═NR60, —CN, —CF3, —OCN, —SCN, —NO, —NO2, ═N2, —N3, —S(O)2O−, —S(O)2OH, —S(O)2R60, —OS(O2)O−, —OS(O)2R60, —P(O)(O)2, —P(O)(OR60)(O−), —OP(O)(OR60)(OR61), —C(O)R60, —C(S)R60, —C(O)OR60, —C(O)NR60R61, —C(O)O−, —C(S)OR60, —NR62C(O)NR62R61, —NR62C(S)NR60R61, —NR62C(NR63)NR60R61, —C(NR62)NR60R61, —S(O)2, —NR60R61, —NR63S(O)2R60, —NR63C(O)R60, and —S(O)R60;
wherein each —R64 is independently a halogen; each R60 and R61 are independently alkyl, substituted alkyl, alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, arylalkyl, substituted arylalkyl, heteroarylalkyl, or substituted heteroarylalkyl, or R60 and R61 together with the nitrogen atom to which they are bonded form a heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, or substituted heteroaryl ring, and R62 and R63 are independently alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, or R62 and R63 together with the atom to which they are bonded form one or more heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, or substituted heteroaryl rings;
wherein the “substituted” substituents, as defined above for R60, R61, R62 and R63, are substituted with one or more, such as one, two, or three, groups independently selected from alkyl, -alkyl-OH, —O-haloalkyl, alkoxy, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, heterocycloalkylalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, —O−, —OH, =O, —O-alkyl, —O-aryl, —O-heteroarylalkyl, —O-cycloalkyl, —O-heterocycloalkyl, —SH, —S−, ═S, —S-alkyl, —S-aryl, —S-heteroarylalkyl, —S-cycloalkyl, —S-heterocycloalkyl, —NH2, ═NH, —CN, —CF3, —OCN, —SCN, —NO, —NO2, =N2, —N3, —S(O)2O−, —S(O)2, —S(O)2OH, —OS(O2)O−, —SO2(alkyl), —SO2(phenyl), —SO2(haloalkyl), —SO2NH2, —SO2NH(alkyl), —SO2NH(phenyl), —P(O)(O)2, —P(O)(O-alkyl)(O), —OP(O)(O-alkyl)(O-alkyl), —CO2H, —C(O)O(alkyl), —CON(alkyl)(alkyl), —CONH(alkyl), —CONH2, —C(O)(alkyl), —C(O)(phenyl), —C(O)(haloalkyl), —OC(O)(alkyl), —N(alkyl)(alkyl), —NH(alkyl), —N(alkyl)(alkylphenyl), —NH(alkylphenyl), —NHC(O)(alkyl), —NHC(O)(phenyl), —N(alkyl)C(O)(alkyl), and —N(alkyl)C(O)(phenyl).
The term “transformer” refers to a device that transfers electrical energy from one contiguous circuit to another contiguous circuit through one or more inductively coupled structures. Exemplary inductively coupled structures include, but are not limited to, at least one of two or more multiply wound, inductively coupled wire coils. Exemplary transformers include, but are not limited to, devices which, alone or in combination with other structures, transfer electrical energy from one circuit to another with a change in voltage, current, phase, or other electric characteristic.
As used in this specification and the appended claims, the articles “a,” “an,” and “the” include plural referents unless expressly and unequivocally limited to one referent.
All numerical ranges herein include all numerical values and ranges of all numerical values within the recited range of numerical values.
The present disclosure relates to estolide compounds, compositions and methods of making the same. In certain embodiments, the present disclosure also relates to estolide compounds, compositions comprising estolide compounds, the synthesis of such compounds, and the formulation of such compositions. In certain embodiments, the present disclosure relates to biosynthetic estolides having desired viscometric properties, while retaining or even improving other properties such as oxidative stability and pour point. In certain embodiments, new methods of preparing estolide compounds exhibiting such properties are provided. The present disclosure also relates to dielectric fluids and electrical devices comprising certain estolide compounds.
In certain embodiments the dielectric fluid comprises at least one estolide compound of Formula I:




wherein
x is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
y is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20;
n is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12;
R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
wherein each fatty acid chain residue of said at least one compound is independently optionally substituted.
In certain embodiments the dielectric fluid comprises at least one estolide compound of Formula II:




wherein
m is an integer greater than or equal to 1;
n is an integer greater than or equal to 0;
R1, independently for each occurrence, is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R3 and R4, independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched.
In certain embodiments the dielectric fluid comprises at least one estolide compound of Formula III:




wherein
x is, independently for each occurrence, an integer selected from 0 to 20;
y is, independently for each occurrence, an integer selected from 0 to 20;
n is an integer greater than or equal to 0;
R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
wherein each fatty acid chain residue of said at least one compound is independently optionally substituted.
In certain embodiments, the dielectric fluid comprises at least one estolide compound of Formula I, II, or III where R1 is hydrogen.
The terms “chain” or “fatty acid chain” or “fatty acid chain residue,” as used with respect to the estolide compounds of Formula I, II, and III, refer to one or more of the fatty acid residues incorporated in estolide compounds, e.g., R3 or R4 of Formula II, or the structures represented by CH3(CH2)yCH(CH2)xC(O)O— in Formula I and III.
The R1 in Formula I, II, and III at the top of each Formula shown is an example of what may be referred to as a “cap” or “capping material,” as it “caps” the top of the estolide. Similarly, the capping group may be an organic acid residue of general formula —OC(O)-alkyl, i.e., a carboxylic acid with a substituted or unsubstituted, saturated or unsaturated, and/or branched or unbranched alkyl as defined herein, or a formic acid residue. In certain embodiments, the “cap” or “capping group” is a fatty acid. In certain embodiments, the capping group, regardless of size, is substituted or unsubstituted, saturated or unsaturated, and/or branched or unbranched. The cap or capping material may also be referred to as the primary or alpha (α) chain.
Depending on the manner in which the estolide is synthesized, the cap or capping group alkyl may be the only alkyl from an organic acid residue in the resulting estolide that is unsaturated. In certain embodiments, it may be desirable to use a saturated organic or fatty-acid cap to increase the overall saturation of the estolide and/or to increase the resulting estolide's stability. For example, in certain embodiments, it may be desirable to provide a method of providing a saturated capped estolide by hydrogenating an unsaturated cap using any suitable methods available to those of ordinary skill in the art. Hydrogenation may be used with various sources of the fatty-acid feedstock, which may include mono- and/or polyunsaturated fatty acids. Without being bound to any particular theory, in certain embodiments, hydrogenating the estolide may help to improve the overall stability of the molecule. However, a fully-hydrogenated estolide, such as an estolide with a larger fatty acid cap, may exhibit increased pour point temperatures. In certain embodiments, it may be desirable to offset any loss in desirable pour-point characteristics by using shorter, saturated capping materials.
The R4C(O)O— of Formula II or structure CH3(CH2)yCH(CH2)xC(O)O— of Formula I and III serve as the “base” or “base chain residue” of the estolide. Depending on the manner in which the estolide is synthesized, the base organic acid or fatty acid residue may be the only residue that remains in its free-acid form after the initial synthesis of the estolide. However, in certain embodiments, in an effort to alter or improve the properties of the estolide, the free acid may be reacted with any number of substituents. For example, it may be desirable to react the free acid estolide with alcohols, glycols, amines, or other suitable reactants to provide the corresponding ester, amide, or other reaction products. The base or base chain residue may also be referred to as tertiary or gamma (γ) chains.
The R3C(O)O— of Formula II or structure CH3(CH2)yCH(CH2)xC(O)O— of Formula I and III are linking residues that link the capping material and the base fatty-acid residue together. There may be any number of linking residues in the estolide, including when n=0 and the estolide is in its dimer form. Depending on the manner in which the estolide is prepared, a linking residue may be a fatty acid and may initially be in an unsaturated form during synthesis. In some embodiments, the estolide will be formed when a catalyst is used to produce a carbocation at the fatty acid's site of unsaturation, which is followed by nucleophilic attack on the carbocation by the carboxylic group of another fatty acid. In some embodiments, it may be desirable to have a linking fatty acid that is monounsaturated so that when the fatty acids link together, all of the sites of unsaturation are eliminated. The linking residue(s) may also be referred to as secondary or beta (β) chains.
In certain embodiments, the cap is an acetyl group, the linking residue(s) is one or more fatty acid residues, and the base chain residue is a fatty acid residue. In certain embodiments, the linking residues present in an estolide differ from one another. In certain embodiments, one or more of the linking residues differs from the base chain residue.
As noted above, in certain embodiments, suitable unsaturated fatty acids for preparing the estolides may include any mono- or polyunsaturated fatty acid. For example, monounsaturated fatty acids, along with a suitable catalyst, will form a single carbocation that allows for the addition of a second fatty acid, whereby a single link between two fatty acids is formed. Suitable monounsaturated fatty acids may include, but are not limited to, palmitoleic acid (16:1), vaccenic acid (18:1), oleic acid (18:1), eicosenoic acid (20:1), erucic acid (22:1), and nervonic acid (24:1). In addition, in certain embodiments, polyunsaturated fatty acids may be used to create estolides. Suitable polyunsaturated fatty acids may include, but are not limited to, hexadecatrienoic acid (16:3), alpha-linolenic acid (18:3), stearidonic acid (18:4), eicosatrienoic acid (20:3), eicosatetraenoic acid (20:4), eicosapentaenoic acid (20:5), heneicosapentaenoic acid (21:5), docosapentaenoic acid (22:5), docosahexaenoic acid (22:6), tetracosapentaenoic acid (24:5), tetracosahexaenoic acid (24:6), linoleic acid (18:2), gamma-linoleic acid (18:3), eicosadienoic acid (20:2), dihomo-gamma-linolenic acid (20:3), arachidonic acid (20:4), docosadienoic acid (20:2), adrenic acid (22:4), docosapentaenoic acid (22:5), tetracosatetraenoic acid (22:4), tetracosapentaenoic acid (24:5), pinolenic acid (18:3), podocarpic acid (20:3), rumenic acid (18:2), alpha-calendic acid (18:3), beta-calendic acid (18:3), jacaric acid (18:3), alpha-eleostearic acid (18:3), beta-eleostearic (18:3), catalpic acid (18:3), punicic acid (18:3), rumelenic acid (18:3), alpha-parinaric acid (18:4), beta-parinaric acid (18:4), and bosseopentaenoic acid (20:5). In certain embodiments, hydroxy fatty acids may be polymerized or homopolymerized by reacting the carboxylic acid functionality of one fatty acid with the hydroxy functionality of a second fatty acid. Exemplary hydroxyl fatty acids include, but are not limited to, ricinoleic acid, 6-hydroxystearic acid, 9,10-dihydroxystearic acid, 12-hydroxystearic acid, and 14-hydroxystearic acid.
The process for preparing the estolide compounds described herein may include the use of any natural or synthetic fatty acid source. However, it may be desirable to source the fatty acids from a renewable biological feedstock. For example, suitable starting materials of biological origin include, but are not limited to, plant fats, plant oils, plant waxes, animal fats, animal oils, animal waxes, fish fats, fish oils, fish waxes, algal oils and mixtures of two or more thereof. Other potential fatty acid sources include, but are not limited to, waste and recycled food-grade fats and oils, fats, oils, and waxes obtained by genetic engineering, fossil fuel-based materials and other sources of the materials desired.
In some embodiments, the estolide comprises fatty-acid chains of varying lengths. In some embodiments, x is, independently for each occurrence, an integer selected from 0 to 20, 0 to 18, 0 to 16, 0 to 14, 1 to 12, 1 to 10, 2 to 8, 6 to 8, or 4 to 6. In some embodiments, x is, independently for each occurrence, an integer selected from 7 and 8. In some embodiments, x is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20.
In some embodiments, y is, independently for each occurrence, an integer selected from 0 to 20, 0 to 18, 0 to 16, 0 to 14, 1 to 12, 1 to 10, 2 to 8, 6 to 8, or 4 to 6. In some embodiments, y is, independently for each occurrence, an integer selected from 7 and 8. In some embodiments, y is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20.
In some embodiments, x+y is, independently for each chain, an integer selected from 0 to 40, 0 to 20, 10 to 20, or 12 to 18. In some embodiments, x+y is, independently for each chain, an integer selected from 13 to 15. In some embodiments, x+y is 15. In some embodiments, x+y is, independently for each chain, an integer selected from 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, and 24.
In some embodiments, the estolide compound of Formula I, II, or III may comprise any number of fatty acid residues to form an “n-mer” estolide. For example, the estolide may be in its dimer (n=0), trimer (n=1), tetramer (n=2), pentamer (n=3), hexamer (n=4), heptamer (n=5), octamer (n=6), nonamer (n=7), or decamer (n=8) form. In some embodiments, n is an integer selected from 0 to 20, 0 to 18, 0 to 16, 0 to 14, 0 to 12, 0 to 10, 0 to 8, or 0 to 6. In some embodiments, n is an integer selected from 0 to 4. In some embodiments, n is 1, wherein said at least one compound of Formula I, II, or III comprises the trimer. In some embodiments, n is greater than 1. In some embodiments, n is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20.
In some embodiments, R1 of Formula I, II, or III is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. In some embodiments, the alkyl group is a C1 to C40 alkyl, C1 to C22 alkyl or C1 to C18 alkyl. In some embodiments, the alkyl group is selected from C7 to C17 alkyl. In some embodiments, R1 is selected from C7 alkyl, C9 alkyl, C11 alkyl, C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R1 is selected from C13 to C17 alkyl, such as from C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R1 is a C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, C18, C19, C20, C21, or C22 alkyl.
In some embodiments, R2 of Formula I, II, or III is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. In some embodiments, the alkyl group is a C1 to C40 alkyl, C1 to C22 alkyl or C1 to C18 alkyl. In some embodiments, the alkyl group is selected from C7 to C17 alkyl. In some embodiments, R2 is selected from C7 alkyl, C9 alkyl, C11 alkyl, C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R2 is selected from C13 to C17 alkyl, such as from C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R2 is a C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, C18, C19, C20, C21, or C22 alkyl.
In some embodiments, R3 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. In some embodiments, the alkyl group is a C1 to C40 alkyl, C1 to C22 alkyl or C1 to C18 alkyl. In some embodiments, the alkyl group is selected from C7 to C17 alkyl. In some embodiments, R3 is selected from C7 alkyl, C9 alkyl, C11 alkyl, C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R3 is selected from C13 to C17 alkyl, such as from C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R3 is a C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, C18, C19, C20, C21, or C22 alkyl.
In some embodiments, R4 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. In some embodiments, the alkyl group is a C1 to C40 alkyl, C1 to C22 alkyl or C1 to C18 alkyl. In some embodiments, the alkyl group is selected from C7 to C17 alkyl. In some embodiments, R4 is selected from C7 alkyl, C9 alkyl, C1, alkyl, C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R4 is selected from C13 to C17 alkyl, such as from C13 alkyl, C15 alkyl, and C17 alkyl. In some embodiments, R4 is a C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17, C18, C19, C20, C21, or C22 alkyl.
As noted above, in certain embodiments, it may be possible to manipulate one or more of the estolides' properties by altering the length of R1 and/or its degree of saturation. However, in certain embodiments, the level of substitution on R1 may also be altered to change or even improve the estolides' properties. Without being bound to any particular theory, in certain embodiments, it is believed that the presence of polar substituents on R1, such as one or more hydroxy groups, may increase the viscosity of the estolide, while increasing pour point. Accordingly, in some embodiments, R1 will be unsubstituted or optionally substituted with a group that is not hydroxyl.
In some embodiments, the estolide is in its free-acid form, wherein R2 of Formula I, II, or III is hydrogen. In some embodiments, R2 is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. In certain embodiments, the R2 residue may comprise any desired alkyl group, such as those derived from esterification of the estolide with the alcohols identified in the examples herein. In some embodiments, the alkyl group is selected from C1 to C40, C1 to C22, C3 to C20, C1 to C18, or C6 to C12 alkyl. In some embodiments, R2 may be selected from C3 alkyl, C4 alkyl, C8 alkyl, C12 alkyl, C16 alkyl, C18 alkyl, and C20 alkyl. For example, in certain embodiments, R2 may be branched, such as isopropyl, isobutyl, or 2-ethylhexyl. In some embodiments, R2 may be a larger alkyl group, branched or unbranched, comprising C12 alkyl, C16 alkyl, C18 alkyl, or C20 alkyl. Such groups at the R2 position may be derived from esterification of the free-acid estolide using the JarcolTM line of alcohols marketed by Jarchem Industries, Inc. of Newark, New Jersey, including JarcolTM I-18CG, I-20, I-12, I-16, I-18T, and 85BJ. In some cases, R2 may be sourced from certain alcohols to provide branched alkyls such as isostearyl and isopalmityl. It should be understood that such isopalmityl and isostearyl akyl groups may cover any branched variation of C16 and C18, respectively. For example, the estolides described herein may comprise highly-branched isopalmityl or isostearyl groups at the R2 position, derived from the Fineoxocol® line of isopalmityl and isostearyl alcohols marketed by Nissan Chemical America Corporation of Houston, Texas, including Fineoxocol® 180, 180N, and 1600. Without being bound to any particular theory, in certain embodiments, large, highly-branched alkyl groups (e.g., isopalmityl and isostearyl) at the R2 position of the estolides can provide at least one way to increase an estolide-containing composition's viscosity, while substantially retaining or even reducing its pour point.
In some embodiments, the compounds described herein may comprise a mixture of two or more estolide compounds of Formula I, II, and III. It is possible to characterize the chemical makeup of an estolide, a mixture of estolides, or a composition comprising estolides, by using the compound's, mixture's, or composition's measured estolide number (EN) of compound or composition. The EN represents the average number of fatty acids added to the base fatty acid. The EN also represents the average number of estolide linkages per molecule:

EN=n+1

wherein n is the number of secondary (β) fatty acids. Accordingly, a single estolide compound will have an EN that is a whole number, for example for dimers, trimers, and tetramers:

dimer EN=1

trimer EN=2

tetramer EN=3

However, a composition comprising two or more estolide compounds may have an EN that is a whole number or a fraction of a whole number. For example, a composition having a 1:1 molar ratio of dimer and trimer would have an EN of 1.5, while a composition having a 1:1 molar ratio of tetramer and trimer would have an EN of 2.5.
In some embodiments, the compositions may comprise a mixture of two or more estolides having an EN that is an integer or fraction of an integer that is greater than 4.5, or even 5.0. In some embodiments, the EN may be an integer or fraction of an integer selected from about 1.0 to about 5.0. In some embodiments, the EN is an integer or fraction of an integer selected from 1.2 to about 4.5. In some embodiments, the EN is selected from a value greater than 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6 and 5.8. In some embodiments, the EN is selected from a value less than 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, and 5.0, 5.2, 5.4, 5.6, 5.8, and 6.0. In some embodiments, the EN is selected from 1, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, and 6.0.
As noted above, it should be understood that the chains of the estolide compounds may be independently optionally substituted, wherein one or more hydrogens are removed and replaced with one or more of the substituents identified herein. Similarly, two or more of the hydrogen residues may be removed to provide one or more sites of unsaturation, such as a cis or trans double bond. Further, the chains may optionally comprise branched hydrocarbon residues. For example, in some embodiments the estolides described herein may comprise at least one compound of Formula II:




wherein
m is an integer equal to or greater than 1;
n is an integer equal to or greater than 0;
R1, independently for each occurrence, is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched;
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R3 and R4, independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched.
In certain embodiments, m is 1. In some embodiments, m is an integer selected from 2, 3, 4, and 5. In some embodiments, n is an integer selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12. In some embodiments, one or more R3 differs from one or more other R3 in a compound of Formula II. In some embodiments, one or more R3 differs from R4 in a compound of Formula II. In some embodiments, if the compounds of Formula II are prepared from one or more polyunsaturated fatty acids, it is possible that one or more of R3 and R4 will have one or more sites of unsaturation. In some embodiments, if the compounds of Formula II are prepared from one or more branched fatty acids, it is possible that one or more of R3 and R4 will be branched.
In some embodiments, R3 and R4 can be CH3(CH2)yCH(CH2)x—, where x is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20, and y is, independently for each occurrence, an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, and 20. Where both R3 and R4 are CH3(CH2)yCH(CH2)x—, the compounds may be compounds according to Formula I and III.
Without being bound to any particular theory, in certain embodiments, altering the EN produces estolide-containing compositions having desired viscometric properties while substantially retaining or even reducing pour point. For example, in some embodiments the estolides exhibit a decreased pour point upon increasing the EN value. Accordingly, in certain embodiments, a method is provided for retaining or decreasing the pour point of an estolide base oil by increasing the EN of the base oil, or a method is provided for retaining or decreasing the pour point of a composition comprising an estolide base oil by increasing the EN of the base oil. In some embodiments, the method comprises: selecting an estolide base oil having an initial EN and an initial pour point; and removing at least a portion of the base oil, said portion exhibiting an EN that is less than the initial EN of the base oil, wherein the resulting estolide base oil exhibits an EN that is greater than the initial EN of the base oil, and a pour point that is equal to or lower than the initial pour point of the base oil. In some embodiments, the selected estolide base oil is prepared by oligomerizing at least one first unsaturated fatty acid with at least one second unsaturated fatty acid and/or saturated fatty acid. In some embodiments, the removing at least a portion of the base oil or a composition comprising two or more estolide compounds is accomplished by use of at least one of distillation, chromatography, membrane separation, phase separation, affinity separation, and solvent extraction. In some embodiments, the distillation takes place at a temperature and/or pressure that is suitable to separate the estolide base oil or a composition comprising two or more estolide compounds into different “cuts” that individually exhibit different EN values. In some embodiments, this may be accomplished by subjecting the base oil or a composition comprising two or more estolide compounds to a temperature of at least about 250° C. and an absolute pressure of no greater than about 25 microns. In some embodiments, the distillation takes place at a temperature range of about 250° C. to about 310° C. and an absolute pressure range of about 10 microns to about 25 microns.
In some embodiments, estolide compounds and compositions exhibit an.EN that is greater than or equal to 1, such as an integer or fraction of an integer selected from about 1.0 to about 2.0. In some embodiments, the EN is an integer or fraction of an integer selected from about 1.0 to about 1.6. In some embodiments, the EN is a fraction of an integer selected from about 1.1 to about 1.5. In some embodiments, the EN is selected from a value greater than 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, and 1.9. In some embodiments, the EN is selected from a value less than 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, and 2.0.
In some embodiments, the EN is greater than or equal to 1.5, such as an integer or fraction of an integer selected from about 1.8 to about 2.8. In some embodiments, the EN is an integer or fraction of an integer selected from about 2.0 to about 2.6. In some embodiments, the EN is a fraction of an integer selected from about 2.1 to about 2.5. In some embodiments, the EN is selected from a value greater than 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, and 2.7. In some embodiments, the EN is selected from a value less than 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, and 2.8. In some embodiments, the EN is about 1.8, 2.0, 2.2, 2.4, 2.6, or 2.8.
In some embodiments, the EN is greater than or equal to about 4, such as an integer or fraction of an integer selected from about 4.0 to about 5.0. In some embodiments, the EN is a fraction of an integer selected from about 4.2 to about 4.8. In some embodiments, the EN is a fraction of an integer selected from about 4.3 to about 4.7. In some embodiments, the EN is selected from a value greater than 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, and 4.9. In some embodiments, the EN is selected from a value less than 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, and 5.0. In some embodiments, the EN is about 4.0, 4.2, 4.4, 4.6, 4.8, or 5.0.
In some embodiments, the EN is greater than or equal to about 5, such as an integer or fraction of an integer selected from about 5.0 to about 6.0. In some embodiments, the EN is a fraction of an integer selected from about 5.2 to about 5.8. In some embodiments, the EN is a fraction of an integer selected from about 5.3 to about 5.7. In some embodiments, the EN is selected from a value greater than 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, and 5.9. In some embodiments, the EN is selected from a value less than 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, and 6.0. In some embodiments, the EN is about 5.0, 5.2, 5.4, 5.4, 5.6, 5.8, or 6.0.
In some embodiments, the EN is greater than or equal to 1, such as an integer or fraction of an integer selected from about 1.0 to about 2.0. In some embodiments, the EN is a fraction of an integer selected from about 1.1 to about 1.7. In some embodiments, the EN is a fraction of an integer selected from about 1.1 to about 1.5. In some embodiments, the EN is selected from a value greater than 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, or 1.9. In some embodiments, the EN is selected from a value less than 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.0. In some embodiments, the EN is about 1.0, 1.2, 1.4, 1.6, 1.8, or 2.0. In some embodiments, the EN is greater than or equal to 1, such as an integer or fraction of an integer selected from about 1.2 to about 2.2. In some embodiments, the EN is an integer or fraction of an integer selected from about 1.4 to about 2.0. In some embodiments, the EN is a fraction of an integer selected from about 1.5 to about 1.9. In some embodiments, the EN is selected from a value greater than 1.0, 1.1. 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, and 2.1. In some embodiments, the EN is selected from a value less than 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, and 2.2. In some embodiments, the EN is about 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, or 2.2.
In some embodiments, the EN is greater than or equal to 2, such as an integer or fraction of an integer selected from about 2.8 to about 3.8. In some embodiments, the EN is an integer or fraction of an integer selected from about 2.9 to about 3.5. In some embodiments, the EN is an integer or fraction of an integer selected from about 3.0 to about 3.4. In some embodiments, the EN is selected from a value greater than 2.0, 2.1, 2.2., 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.4, 3.5, 3.6, and 3.7. In some embodiments, the EN is selected from a value less than 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, and 3.8. In some embodiments, the EN is about 2.0, 2.2, 2.4, 2.6, 2.8, 3.0, 3.2, 3.4, 3.6, or 3.8. Typically, base stocks and estolide-containing compositions exhibit certain lubricity, viscosity, and/or pour point characteristics. For example, in certain embodiments, the base oils, compounds, and compositions may exhibit viscosities that range from about 10 cSt to about 250 cSt at 40° C., and/or about 3 cSt to about 30 cSt at 100° C. In some embodiments, the base oils, compounds, and compositions may exhibit viscosities within a range from about 50 cSt to about 150 cSt at 40° C., and/or about 10 cSt to about 20 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities less than about 55 cSt at 40° C. or less than about 45 cSt at 40° C., and/or less than about 12 cSt at 100° C. or less than about 10 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 25 cSt to about 55 cSt at 40° C., and/or about 5 cSt to about 11 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 35 cSt to about 45 cSt at 40° C., and/or about 6 cSt to about 10 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 38 cSt to about 43 cSt at 40° C., and/or about 7 cSt to about 9 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities less than about 120 cSt at 40° C. or less than about 100 cSt at 40° C., and/or less than about 18 cSt at 100° C. or less than about 17 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 70 cSt to about 120 cSt at 40° C., and/or about 12 cSt to about 18 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 80 cSt to about 100 cSt at 40° C., and/or about 13 cSt to about 17 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 85 cSt to about 95 cSt at 40° C., and/or about 14 cSt to about 16 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities greater than about 180 cSt at 40° C. or greater than about 200 cSt at 40° C., and/or greater than about 20 cSt at 100° C. or greater than about 25 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 180 cSt to about 230 cSt at 40° C., and/or about 25 cSt to about 31 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 200 cSt to about 250 cSt at 40° C., and/or about 25 cSt to about 35 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 210 cSt to about 230 cSt at 40° C., and/or about 28 cSt to about 33 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 200 cSt to about 220 cSt at 40° C., and/or about 26 cSt to about 30 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 205 cSt to about 215 cSt at 40° C., and/or about 27 cSt to about 29 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities less than about 45 cSt at 40° C. or less than about 38 cSt at 40° C., and/or less than about 10 cSt at 100° C. or less than about 9 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 20 cSt to about 45 cSt at 40° C., and/or about 4 cSt to about 10 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 28 cSt to about 38 cSt at 40° C., and/or about 5 cSt to about 9 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 30 cSt to about 35 cSt at 40° C., and/or about 6 cSt to about 8 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities less than about 80 cSt at 40° C. or less than about 70 cSt at 40° C., and/or less than about 14 cSt at 100° C. or less than about 13 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 50 cSt to about 80 cSt at 40° C., and/or about 8 cSt to about 14 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 60 cSt to about 70 cSt at 40° C., and/or about 9 cSt to about 13 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 63 cSt to about 68 cSt at 40° C., and/or about 10 cSt to about 12 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities greater than about 120 cSt at 40° C. or greater than about 130 cSt at 40° C., and/or greater than about 15 cSt at 100° C. or greater than about 18 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 120 cSt to about 150 cSt at 40° C., and/or about 16 cSt to about 24 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 130 cSt to about 160 cSt at 40° C., and/or about 17 cSt to about 28 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 130 cSt to about 145 cSt at 40° C., and/or about 17 cSt to about 23 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities within a range from about 135 cSt to about 140 cSt at 40° C., and/or about 19 cSt to about 21 cSt at 100° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, 270, 280, 290, 300, 350, or 400 cSt. at 40° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, and 30 cSt at 100° C.
In some embodiments, the estolide compounds and compositions may exhibit viscosities less than about 200, 250, 300, 350, 400, 450, 500, or 550 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 200 cSt to about 250 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 250 cSt to about 300 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 300 cSt to about 350 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 350 cSt to about 400 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 400 cSt to about 450 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 450 cSt to about 500 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit a viscosity within a range from about 500 cSt to about 550 cSt at 0° C. In some embodiments, the estolide compounds and compositions may exhibit viscosities of about 100, 125, 150, 175, 200, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, 500, 525, or 550 cSt at 0° C.
In some embodiments, estolide compounds and compositions may exhibit desirable low-temperature pour point properties. In some embodiments, the estolide compounds and compositions may exhibit a pour point lower than about −25° C., about −35° C., −40° C., or even about −50° C. In some embodiments, the estolide compounds and compositions have a pour point of about −25° C. to about −45° C. In some embodiments, the pour point falls within a range of about −30° C. to about −40° C., about −34° C. to about −38° C., about −30° C. to about −45° C., −35° C. to about −45° C., 34° C. to about −42° C., about −38° C. to about −42° C., or about 360C. to about −40° C. In some embodiments, the pour point falls within the range of about −27° C. to about −37° C., or about −30° C. to about −34° C. In some embodiments, the pour point falls within the range of about −25° C. to about −35° C., or about −28° C. to about −32° C. In some embodiments, the pour point falls within the range of about −28° C. to about −38° C., or about −31° C. to about −35° C. In some embodiments, the pour point falls within the range of about −31° C. to about −41° C., or about −34° C. to about −38° C. In some embodiments, the pour point falls within the range of about −40° C. to about −50° C., or about −42° C. to about −48° C. In some embodiments, the pour point falls within the range of about −50° C. to about −60° C., or about −52° C. to about −58° C. In some embodiments, the upper bound of the pour point is less than about −35° C., about −360C., about −37° C., about −38° C., about −39° C., about −40° C., about −41° C., about −42° C., about −43° C., about −44° C., or about −45° C. In some embodiments, the lower bound of the pour point is greater than about −70° C., about −69° C., about −68° C., about −67° C., about −660C., about −65° C., about −64° C., about −63° C., about −62° C., about −61° C., about −60° C., about −59° C., about −58° C., about −57° C., about −560C., −55° C., about −54° C., about −53° C., about −52° C., −51, about −50° C., about −49° C., about −48° C., about −47° C., about −460C., or about −45° C.
In addition, in certain embodiments, the estolides may exhibit decreased Iodine Values (IV) when compared to estolides prepared by other methods. IV is a measure of the degree of total unsaturation of an oil, and is determined by measuring the amount of iodine per gram of estolide (cg/g). In certain instances, oils having a higher degree of unsaturation may be more susceptible to creating corrosiveness and deposits, and may exhibit lower levels of oxidative stability. Compounds having a higher degree of unsaturation will have more points of unsaturation for iodine to react with, resulting in a higher IV. Thus, in certain embodiments, it may be desirable to reduce the IV of estolides in an effort to increase the oil's oxidative stability, while also decreasing harmful deposits and the corrosiveness of the oil.
In some embodiments, estolide compounds and compositions described herein have an IV of less than about 40 cg/g or less than about 35 cg/g. In some embodiments, estolides have an IV of less than about 30 cg/g, less than about 25 cg/g, less than about 20 cg/g, less than about 15 cg/g, less than about 10 cg/g, or less than about 5 cg/g. The IV of a composition may be reduced by decreasing the estolide's degree of unsaturation. This may be accomplished by, for example, by increasing the amount of saturated capping materials relative to unsaturated capping materials when synthesizing the estolides. Alternatively, in certain embodiments, IV may be reduced by hydrogenating estolides having unsaturated caps.
In certain embodiments, the estolide compounds and compositions described herein may be used to prepare dielectric fluids. In certain embodiments, the dielectric fluids will meet one or more of the ASTM standards set forth in Designation: D6871-03 (Reapproved 2008), which is the ASTM Standard Specification for Natural (Vegetable Oil) Ester Fluids Used in Electrical Apparatus. In certain embodiments, the dielectric fluids meet or exceed one or more, or all of, the minimum testing standards set forth in Designation: D6871-03 (Reapproved 2008), such as the following:














ASTM Test


Property
Limit
Method















Physical









Color, max
1.0
D1500


Fire point, min, ° C.
300
D92


Flash point, min, ° C.
275
D92


Pour point, max, ° C.
−10
D97


Relative Density (specific gravity)
0.96
D1298


15° C./15° C., max


Viscosity, max, cSt at:

D445 or




D88


100° C. (212° F.)
15


40° C. (104° F.)
50


0° C. (32° F.)
500


Visual Examination
Bright and Clear
D1524







Electrical









Dielectric breakdown voltage at 60 Hz




Disk electrodes, min, kV
30
D877


VDE electrodes, min, kV @

D1816


1 mm (0.04 in.) gap
20


2 mm (0.08 in.) gap
35


Dielectric breakdown voltage,
130
D3300


impulse conditions 25° C.,


min, kV, needle negative to sphere


ground 1 in. (25.4 mm) gap


Dissipation factor (or power

D924


factor) at 60 Hz, max, % @


25° C.
0.20


100° C.
4.0


Gassing tendency, max, μl/min
0
D2300







Chemical









Corrosive sulfur
Not corrosive
D1275


Neutralization number, total
0.06
D974


acid number, max, mg KOH/g


PCB content, ppm
Not detectable
D4059


Water, max, mg/kg
200
D1533









In certain embodiments, the dielectric fluid will meet 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, or 19 of the minimum testing standards set forth in Designation: D6871-03 (Reapproved 2008).
In certain embodiments, the dielectric fluid has a conductivity of less than or equal to about 50 pS/M (picosiemens/meter) at 25° C., such as about 0 to about 25 or about 0 to about 15 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of less than or equal to about 15 pS/M at 25° C., such as about 0 to about 10 or about 0 to about 5 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of less than or equal to about 5 pS/M at 25° C., such as about 0 to about 2 or about 0 to about 1 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of less than or equal to about 1 pS/M at 25° C., such as about 0.1 to about 0.5 or about 0.5 to about 1 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of about 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of about 0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2 pS/M at 25° C. In certain embodiments, the dielectric fluid has a conductivity of about 2.2, 2.4, 2.6, 2.8, 3, 3.2, 3.4, 3.6, 3.8, 4, 4.2, 4.4, 4.6, 4.8 or 5 pS/M at 25° C.
In certain embodiments, the dielectric fluid has a dielectric strength of at least about 20 kV/mm (1 mm gap), such as about 20 to about 100 or 20 to about 50 kV/mm (1 mm gap). In certain embodiments, the dielectric fluid has a dielectric strength of about 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 kV/mm (1 mm gap).
In certain embodiments, the dielectric fluid has a kinematic viscosity essentially the same as the kinematic viscosity for the estolide compounds included in the dielectric fluid. In certain embodiments, the dielectric fluid has a kinematic viscosity within approximately 1% or approximately 2% of the kinematic viscosity of the estolide compounds included within the dielectric fluid. In certain embodiments, the dielectric fluid has a kinematic viscosity within 0.2%, 0.4%, 0.6%, 0.8%, 1.0%, 1.2%, 1.4%, 1.6%, 1.8%, or 2% of the kinematic viscosity of the estolide compounds included in the dielectric fluid. In certain embodiments, the dielectric fluid has a kinematic viscosity that is less than or equal to about 15 cSt at 100° C. In certain embodiments, the dielectric fluid has a kinematic viscosity that is less than or equal to about 50 cSt at 40° C. In certain embodiments, the dielectric fluid has a kinematic viscosity that is less than or equal to about 500 cSt at 0° C.
In certain embodiments, the dielectric fluid has a fire point of greater than or equal to about 300° C. In certain embodiments, the dielectric fluid has a fire point of about 300° C. to about 400° C., or about 300° C. to about 350° C. In certain embodiments, dielectric fluid has a fire point of about 300° C. to about 310° C. In certain embodiments, the dielectric fluid has a fire point of about 300° C., about 305° C., about 310° C., about 315° C., about 320° C., about 325° C., about 330° C., about 335° C., about 340° C., about 345° C., about 350° C., about 355° C., about 360° C., about 365° C., about 370° C., about 375° C., about 380° C., about 385° C., about 390° C., about 395° C., or about 400° C.
In certain embodiments, the dielectric fluid has a flash point of greater than or equal to about 275° C. In certain embodiments, the dielectric fluid has a flash point of about 275° C. to about 375° C., about 275° C. to about 350° C., or about 275° C. to about 325° C. In certain embodiments, the dielectric fluid has a flash point of about 275° C. to about 300° C. In certain embodiments, the dielectric fluid has a flash point of about 300° C. to about 310° C. In certain embodiments, the dielectric fluid has a flash point of about 275° C., about 280° C., about 285° C., about 290° C., about 295° C., about 300° C., about 305° C., about 310° C., about 315° C., about 320° C., about 325° C., about 330° C., about 335° C., about 340° C., about 345° C., about 350° C., about 355° C., about 360° C., about 365° C., about 370° C., or about 375° C.
In certain embodiments, the dielectric fluid has a relative density of less than or equal to about 1. In certain embodiments, the dielectric fluid has a relative density of less than or equal to about 0.96. In certain embodiments, the dielectric fluid has a relative density of about 0.5 to about 1, or about 0.75 to about 1. In certain embodiments, the dielectric fluid has a relative density of about 0.85 to about 0.95. In certain embodiments, the dielectric fluid has a relative density of about 0.5, about 0.52, about 0.54, about 0.56, about 0.58, about 0.6, about 0.62, about 0.64, about 0.66, about 0.68, about 0.7, about 0.72, about 0.74 about 0.76, about 0.78, about 0.8, about 0.82, about 0.84, about 0.86, about 0.88, about 0.9, about 0.92, about 0.94, or about 0.96.
In certain embodiments, the dielectric fluid has a color of less than or equal to about 1. In certain embodiments, the dielectric fluid has a color of about 0.5 to about 1, or about 0.75 to about 1. In certain embodiments, the dielectric fluid has a color of about 0.85 to about 0.95. In certain embodiments, the dielectric fluid has a color of about 0.5, about 0.52, about 0.54, about 0.56, about 0.58, about 0.6, about 0.62, about 0.64, about 0.66, about 0.68, about 0.7, about 0.72, about 0.74 about 0.76, about 0.78, about 0.8, about 0.82, about 0.84, about 0.86, about 0.88, about 0.9, about 0.92, about 0.94, about 0.96, about 0.98, or about 1.
In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (disk electrodes) of greater than or equal to about 30 kV, such as about 30 kV to about 60 or about 30 kV to about 45 kV. In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (disk electrodes) of about 30 kV, about 32 kV, about 34 kV, about 36 kV, about 38 kV, about 40 kV, about 42 kV, about 44 kV, about 46 kV, about 48 kV, about 50 kV, about 52 kV, about 54 kV, about 56 kV, about 58 kV, or about 60 kV.
In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (VDE electrodes) of greater than or equal to about 20 kV for a 1 mm gap, such as about 20 kV to about 60 or about 20 kV to about 45 kV. In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (VDE electrodes) of about 20 kV, about 22 kV, about 24 kV, about 26 kV, about 28 kV, about 36 kV, about 32 kV, about 34 kV, about 36 kV, about 38 kV, about 40 kV, about 42 kV, about 44 kV, about 46 kV, about 48 kV, about 50 kV, about 52 kV, about 54 kV, about 56 kV, about 58 kV, or about 60 kV for a 1 mm gap.
In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (VDE electrodes) of greater than or equal to about 35 kV for a 2 mm gap, such as about 35 kV to about 60 or about 35 kV to about 45 kV. In certain embodiments, the dielectric fluid has a dielectric breakdown voltage at 60 Hz (disk electrodes) of about 30 kV, about 32 kV, about 34 kV, about 36 kV, about 38 kV, about 40 kV, about 42 kV, about 44 kV, about 46 kV, about 48 kV, about 50 kV, about 52 kV, about 54 kV, about 56 kV, about 58 kV, or about 60 kV for a 2 mm gap.
In certain embodiments, the dielectric fluid has a dielectric breakdown voltage under impulse conditions (25° C., needle negative to sphere grounded, 1 in.) of greater than or equal to about 130 kV, such as about 130 kV to about 200 kV, or about 130 kV to about 175 kV. In certain embodiments, the dielectric fluid has a dielectric breakdown voltage under impulse conditions (25° C., needle negative to sphere grounded, 1 in.) of about 130 kV, about 135 kV, about 140 kV, about 145 kV, about 150 kV, about 155 kV, about 160 kV, about 165 kV, about 170 kV, about 175 kV, about 180 kV, about 185 kV, about 190 kV, about 195 kV, or about 200 kV.
In certain embodiments, the dielectric fluid has a dissipation factor at 60 Hz of less than or equal to about 0.2% at 25° C., such as about 0% to about 0.2%, or about 0.1% to about 0.2%. In certain embodiments, the dielectric fluid has a dissipation factor at 60 Hz of about 0%, about 0.02%, about 0.04%, about 0.06%, about 0.08%, about 0.1%, about 0.12%, about 0.14%, about 0.16%, about 0.18%, or about 0.2% at 25° C.
In certain embodiments, the dielectric fluid has a dissipation factor at 60 Hz of less than or equal to about 4% at 100° C., such as about 0% to about 4%, or about 0% to about 2%. In certain embodiments, the dielectric fluid has a dissipation factor at 60 Hz of about 0%, about 0. 2%, about 0.4%, about 0.6%, about 0.8%, about 1%, about 1.2%, about 1.4%, about 1.6%, about 1.8%, about 2%, about 2.2%, about 2.4%, about 2.6%, about 2.8%, about 3%, about 3.2%, about 3.4%, about 3.6%, about 3.8%, or about 4% at 100° C.
In certain embodiments, the dielectric fluid has a gassing tendency of about 0 μl/min. In certain embodiments, the dielectric fluid tests negative for sulfur corrosion. In certain embodiments, the dielectric fluid has a total acid number equal to or less than about 0.1 mg KOH/g, such as about 0.06 to 0.1 mg KOH/g. In certain embodiments, the dielectric fluid has a total acid number equal to or less than about 0.06 mg KOH/g. In certain embodiments, the dielectric fluid has a total acid number of about 0.02 to about 0.06 mg KOH/g. In certain embodiments, the dielectric fluid has a total acid number of about 0, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, or 0.1 mg KOH/g.
In certain embodiments, the dielectric fluid has a PCB (polychlorinated biphenyls) content of about 0 ppm. In certain embodiments, the dielectric fluid has a water content of less than or equal to about 200 mg/kg, such as about 100 to about 200 mg/kg. In certain embodiments, the dielectric fluid has a water content of less than or equal to about 200 mg/kg, such as about 0 to about 100 mg/kg, or about 50 to about 100 mg/kg. In certain embodiments, the dielectric fluid has a water content of less than or equal to about 50 mg/kg, such as about 25 to about 50 mg/kg, or about 0 to about 25 mg/kg. In certain embodiments, the dielectric fluid has a water content of about 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, or 200 mg/kg.
In certain embodiments, the dielectric fluid comprises or consists essentially of an estolide base oil, wherein said base oil comprises at least one compound of Formulas I, II, and/or III. In certain embodiments, the dielectric fluid further comprises at least one additive, wherein the at least one additive may be selected from antioxidants, antimicrobial agents, cold flow modifiers, pour point modifiers, metal chelating agents, and metal deactivators.
In certain embodiments, the at least one additive includes at least one antioxidant. In certain embodiments, the at least one antioxidant is a phenolic antioxidant. Exemplary antioxidants include, but are not limited to, butylated hydroxy toluene (BHT), butylated hydroxy anisole (BHA), 2,6-ditertiary-butyl paracresol (DBPC), mono-tertiary butyl hydro quinone (TBHQ), tetrahydro butyrophenone (THBP), and one or more alkylated diphenylamines. In certain embodiments, antioxidants are used in combinations, such as a combination comprising BHA and BHT. In certain embodiments, antioxidant(s) may comprise about 0% to about 5% wt. % of the dielectric fluid, such as about 0.1% to about 3%. In certain embodiments, oxidation stability of the oil may be determined by AOM (anaerobic oxidation of methane) or OSI (oxidation stability index) methods known to those skilled in the art.
In certain embodiments, the at least one additive includes at least one antimicrobial agent. In certain embodiments, the at least one antimicrobial agent inhibits the growth of microorganisms. In certain embodiments, the at least one antimicrobial agent is any antimicrobial substance that is compatible with the dielectric fluid may be blended into the fluid. In certain embodiments, compounds that are useful as antioxidants also may be used as antimicrobials. For example, in certain embodiments, phenolic antioxidants such as BHA may also exhibit some activity against one or more of bacteria, molds, viruses and protozoa. In certain embodiments, the at least one antioxidant may be added with at least one antimicrobial agent selected from one or more of potassium sorbate, sorbic acid, and monoglycerides. Other exemplary antimicrobials include, but are not limited to, vitamin E and ascorbyl palmitate.
In certain embodiments, the at least one additive includes at least one pour point depressant and/or cold flow modifier. In certain embodiments, the at least one pour point depressant and/or cold flow modifier is present at levels of about 0 wt. % to about 5 wt. %, such as about 0.1 wt. % to about 3 wt. %. In certain embodiments, the at least one pour point depressant is selected from one or more of polyvinyl acetate oligomers, polyvinyl acetate polymers, acrylic oligomers, or acrylic polymers. In certain embodiments, the at least one pour point depressant is polymethacrylate (PMA). In certain embodiments, the pour point may be further reduced by winterizing processed oil. In certain embodiments, oils are winterized by lowering the temperature to near or below about 0° C. and removing solidified components. In certain embodiments, the winterization process may be performed as a series of temperature reductions followed by removal of solids at the various temperatures. In certain embodiments, winterization is performed by reducing the temperature serially to about 5° C., about 0° C. and about −12° C. for several hours, and filtering with diatomaceous earth to remove solids.
In certain embodiments, the at least one additive includes at least one metal chelating agent and/or one metal deactivator. Since metals like copper may be present in the electrical environment, in certain embodiments the dielectric fluid may include at least one metal deactivator. Exemplary metal deactivators include, but are not limited to, copper deactivators. Exemplary metal deactivators include, but are not limited to, benzotriazole derivatives. In certain embodiments, the dielectric fluid comprises at least one metal deactivator in an amount equal to or lower than about 1 wt. %, such as about 0.1 wt. % to about 0.5 wt. %.
In certain embodiments, the dielectric fluid includes a combination of additives, such as a combination of aminic and phenolic antioxidants and/or triazole metal deactivators. An exemplary combination includes, but is not limited to, Irganox® L-57 antioxidant, Irganox® L-109 antioxidant, and Irgamet®-30 metal deactivator, which are each commercially available from Ciba-Geigy, Inc. (Tarrytown, N.Y.).
In certain embodiments, the dielectric fluid comprises at least one colorant. In certain embodiments, the at least one colorant is selected from dyes and pigments. In certain embodiments, any known dyes and/or pigments can be used, such as those available commercially as food additives. In certain embodiments, the dyes and pigments may be selected from oil soluble dyes and pigments. In certain embodiments, the at least one colorant is present in the composition in minor amounts, such as less than about 1 ppm.
In certain embodiments, the dielectric fluid comprises a co-blend of at least one estolide base oil or at least one estolide compound along with at least one additive, wherein the at least one additive may be selected from polyalphaolefins, synthetic esters, polyalkylene glycols, mineral oils (Groups I, II, and III), vegetable and animal-based oils (e.g., mono, di-, and tri-glycerides), and fatty-acid esters. Exemplary mineral oils include, but are not limited to, those available from Petro-Canada under the trade designation Luminol TR, those available from Calumet Lubricating Co. under the trade designation Caltran 60-15, and those available from Ergon Refining Inc. under the trade designation Hivolt II. Exemplary polyalphaolefins include, but are not limited to, those having a viscosity from about 2 cSt to about 14 cSt at 100° C., which are available from Chevron under the trade designation Synfluid PAO, Amoco under the trade designation Durasyn, and Ethyl Corp. under the trade designation Ethylflo. In certain embodiments, the polyalphaolefin has a viscosity from about 4 cSt to about 8 cSt at 100° C., and may originate from oligomers such as dimers, trimers, and tetramers. In certain embodiments, the oligomers may comprise chains of 2 to 40 carbons, or chains of 2 to 20 carbons. In certain embodiments, the polyalphaolefins may comprise chains of 6 to 12 carbons, such as chains of 10 carbons. In certain embodiments, the polyalphaolefin has viscosity from about 6 cSt to about 8 cSt at 100° C.
In certain embodiments, the dielectric fluid is introduced into at least one electrical device in a manner that minimizes the exposure of the fluid to atmospheric oxygen, moisture, and other contaminants that could adversely affect their performance. In certain embodiments, the at least one electrical device comprises at least one tank adapted to contain a fluid and/or a gas. In certain embodiments, the tank is defined, at least in part, by a housing. In certain embodiments, the process of introducing the dielectric fluid into at least one electrical device includes at least partially drying the tank contents, evacuating and substituting at least a portion of air present in the tank with an inert gas, filling at least a portion of the tank with the dielectric fluid, and sealing the tank thereafter. In certain embodiments, at least a portion of the process of introducing the dielectric fluid into at least one electrical device is conducted under partial vacuum. In certain embodiments, the electrical device and/or its operation requires a headspace between the dielectric fluid and a tank cover. In certain embodiments, gas present in the headspace may be partially or completely evacuated and partially or completely substituted with an inert gas. In certain embodiments, the inert gas is introduced into the electrical device after filling and otherwise sealing the tank. Exemplary inert gases include, but are not limited to, nitrogen gas.
In certain embodiments, the electrical device comprises at least one electrical transformer and/or switchgear. In certain embodiments, the electrical device comprises at least one electrical transmission line, such as a fluid-filled transmission cable. In certain embodiments, the at least one electrical transformer and/or switchgear is constructed such that at least a portion of at least one circuit can be immersed in a dielectric fluid. For example, in a transformer, at least a portion of the core and windings (i.e., core/coil assembly) can be immersed in a dielectric fluid. In certain embodiments, immersed components can be enclosed in a sealed housing or tank. In certain embodiments, the windings may also be wrapped with a cellulose or paper material. In certain embodiments, the dielectric fluid compositions provide at least some protection, and extend the useful service life, of the cellulose chains of the paper insulating material.
In certain embodiments, the dielectric fluid is used to retrofill existing electrical equipment that incorporates other (e.g., less desirable) dielectric fluids. In certain embodiments, retrofilling existing electrical devices is accomplished using any suitable method known in the art. In certain embodiments, the components of the electrical devices are optionally dried prior to the introduction of the dielectric fluid. In certain embodiments, the electrical devices include cellulose or paper wrapping, which may be implemented to absorb moisture over time.
The present disclosure further relates to use of estolide compounds and estolide-containing compositions as an insulating medium in manufacturing processes wherein the material is shaped by application of electrical energy. Exemplary manufacturing processes utilizing estolide compounds and/or estolide-containing compositions as an insulating medium include, but are not limited to, electrical discharge machining (EDM). Also referred to as, for example, spark machining, spark eroding, burning, die sinking, or wire erosion, EDM processes, for example, can be conducted with a fluid with sufficiently low conductivity comprising at least one estolide. In some embodiments, EDM processes may be conducted with dielectric fluid. In some embodiments, EDM processes may be conducted with an insulating medium with a conductivity that is greater than 1 picosiemens per meter. In some embodiments, the insulating medium and/or dielectric fluid used is partially or completely biodegradable. In some embodiments, EDM processes may be conducted with insulating fluid or dielectric fluid that has low or no toxicity.
The present disclosure further relates to methods of making estolides according to Formula I, II, and III. By way of example, the reaction of an unsaturated fatty acid with an organic acid and the esterification of the resulting free acid estolide are illustrated and discussed in the following Schemes 1 and 2. The particular structural formulas used to illustrate the reactions correspond to those for synthesis of compounds according to Formula I and III; however, the methods apply equally to the synthesis of compounds according to Formula II, with use of compounds having structure corresponding to R3 and R4 with a reactive site of unsaturation.
As illustrated below, compound 100 represents an unsaturated fatty acid that may serve as the basis for preparing the estolide compounds described herein.




In Scheme 1, wherein x is, independently for each occurrence, an integer selected from 0 to 20, y is, independently for each occurrence, an integer selected from 0 to 20, n is an integer greater than or equal to 1, and R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, unsaturated fatty acid 100 may be combined with compound 102 and a proton from a proton source to form free acid estolide 104. In certain embodiments, compound 102 is not included, and unsaturated fatty acid 100 may be exposed alone to acidic conditions to form free acid estolide 104, wherein R1 would represent an unsaturated alkyl group. In certain embodiments, if compound 102 is included in the reaction, R1 may represent one or more optionally substituted alkyl residues that are saturated or unsaturated and branched or unbranched. Any suitable proton source may be implemented to catalyze the formation of free acid estolide 104, including but not limited to homogenous acids and/or strong acids like hydrochloric acid, sulfuric acid, perchloric acid, nitric acid, triflic acid, and the like.




Similarly, in Scheme 2, wherein x is, independently for each occurrence, an integer selected from 0 to 20, y is, independently for each occurrence, an integer selected from 0 to 20, n is an integer greater than or equal to 1, and R1 and R2 are each an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched, free acid estolide 104 may be esterified by any suitable procedure known to those of skilled in the art, such as acid-catalyzed reduction with alcohol 202, to yield esterified estolide 204. Other exemplary methods may include other types of Fischer esterification, such as those using Lewis acid catalysts such as BF3.
In all of the foregoing examples, the compounds described may be useful alone, as mixtures, or in combination with other compounds, compositions, and/or materials.
Methods for obtaining the novel compounds described herein will be apparent to those of ordinary skill in the art, suitable procedures being described, for example, in the examples below, and in the references cited herein.
EXAMPLES
Analytics
Nuclear Magnetic Resonance: NMR spectra were collected using a Bruker Avance 500 spectrometer with an absolute frequency of 500.113 MHz at 300 K using CDCl3 as the solvent. Chemical shifts were reported as parts per million from tetramethylsilane. The formation of a secondary ester link between fatty acids, indicating the formation of estolide, was verified with NMR by a peak at about 4.84 ppm.
Estolide Number (EN): The EN was measured by GC analysis. It should be understood that the EN of a composition specifically refers to EN characteristics of any estolide compounds present in the composition. Accordingly, an estolide composition having a particular EN may also comprise other components, such as natural or synthetic additives, other non-estolide base oils, fatty acid esters, e.g., triglycerides, and/or fatty acids, but the EN as used herein, unless otherwise indicated, refers to the value for the estolide fraction of the estolide composition.
Iodine Value (IV): The iodine value is a measure of the degree of total unsaturation of an oil. IV is expressed in terms of centigrams of iodine absorbed per gram of oil sample. Therefore, the higher the iodine value of an oil the higher the level of unsaturation is of that oil. The IV may be measured and/or estimated by GC analysis. Where a composition includes unsaturated compounds other than estolides as set forth in Formula I, II, and III, the estolides can be separated from other unsaturated compounds present in the composition prior to measuring the iodine value of the constituent estolides. For example, if a composition includes unsaturated fatty acids or triglycerides comprising unsaturated fatty acids, these can be separated from the estolides present in the composition prior to measuring the iodine value for the one or more estolides.
Acid Value: The acid value is a measure of the total acid present in an oil. Acid value may be determined by any suitable titration method known to those of ordinary skill in the art. For example, acid values may be determined by the amount of KOH that is required to neutralize a given sample of oil, and thus may be expressed in terms of mg KOH/g of oil.
Gas Chromatography (GC): GC analysis was performed to evaluate the estolide number (EN) and iodine value (IV) of the estolides. This analysis was performed using an Agilent 6890N series gas chromatograph equipped with a flame-ionization detector and an autosampler/injector along with an SP-2380 30 m×0.25 mm i.d. column.
The parameters of the analysis were as follows: column flow at 1.0 mL/min with a helium head pressure of 14.99 psi; split ratio of 50:1; programmed ramp of 120-135° C. at 20° C./min, 135-265° C. at 7° C./min, hold for 5 min at 265° C.; injector and detector temperatures set at 250° C.
Measuring EN and IV by GC: To perform these analyses, the fatty acid components of an estolide sample were reacted with MeOH to form fatty acid methyl esters by a method that left behind a hydroxy group at sites where estolide links were once present. Standards of fatty acid methyl esters were first analyzed to establish elution times.
Sample Preparation: To prepare the samples, 10 mg of estolide was combined with 0.5 mL of 0.5M KOH/MeOH in a vial and heated at 100° C. for 1 hour. This was followed by the addition of 1.5 mL of 1.0 M H2SO4/MeOH and heated at 100° C. for 15 minutes and then allowed to cool to room temperature. One (1) mL of H2O and 1 mL of hexane were then added to the vial and the resulting liquid phases were mixed thoroughly. The layers were then allowed to phase separate for 1 minute. The bottom H2O layer was removed and discarded. A small amount of drying agent (Na2SO4 anhydrous) was then added to the organic layer after which the organic layer was then transferred to a 2 mL crimp cap vial and analyzed.
EN Calculation: The EN is measured as the percent hydroxy fatty acids divided by the percent non-hydroxy fatty acids. As an example, a dimer estolide would result in half of the fatty acids containing a hydroxy functional group, with the other half lacking a hydroxyl functional group. Therefore, the EN would be 50% hydroxy fatty acids divided by 50% non-hydroxy fatty acids, resulting in an EN value of 1 that corresponds to the single estolide link between the capping fatty acid and base fatty acid of the dimer.
IV Calculation: The iodine value is estimated by the following equation based on ASTM Method D97 (ASTM International, Conshohocken, Pa.):




  IV
  =
  
    ∑
    
      100
      ×
      
        
          
            A
            f
          
          ×
          M
          ⁢
          
            
          
          ⁢
          
            W
            I
          
          ×
          db
        
        
          M
          ⁢
          
            
          
          ⁢
          
            W
            f
          
        
      
    
  




    
    
        Af=fraction of fatty compound in the sample
        MW1=253.81, atomic weight of two iodine atoms added to a double bond
        db=number of double bonds on the fatty compound
        MWf=molecular weight of the fatty compound
    
    


The properties of exemplary estolide compounds and compositions described herein are identified in the following examples and tables.
Other Measurements: Except as otherwise described, color is measured by ASTM Method D1500, dielectric breakdown voltage at 60 Hz is measured by ASTM Method D877 (disk electrodes, kV) and D1816 (VDE electrodes, kV), dielectric breakdown voltage under impulse conditions is measured by ASTM Method D3300, dissipation factor at 60 Hz is measured by ASTM method D924, gassing tendency is measured by ASTM Method D2300, corrosive sulfurization is measured by ASTM Method D1275, neutralization number (TAN) is measured by ASTM Method D974, PCB content is measured by ASTM Method D4059, water content is measured by ASTM Method D1533, relative density is measured by ASTM Method D1298, pour point is measured by ASTM Method D97-96a, cloud point is measured by ASTM Method D2500, viscosity/kinematic viscosity is measured by ASTM Method D445-97, viscosity index is measured by ASTM Method D2270-93 (Reapproved 1998), specific gravity is measured by ASTM Method D4052, fire point and flash point are measured by ASTM Method D92, evaporative loss is measured by ASTM Method D5800, vapor pressure is measured by ASTM Method D5191, and acute aqueous toxicity is measured by Organization of Economic Cooperation and Development (OECD) 203.
Example 1
The acid catalyst reaction was conducted in a 50 gallon Pfaudler RT-Series glass-lined reactor. Oleic acid (65 Kg, OL 700, Twin Rivers) was added to the reactor with 70% perchloric acid (992.3 mL, Aldrich Cat#244252) and heated to 60° C. in vacuo (10 torr abs (Torr absolute; 1 torr=−1 mmHg)) for 24 hrs while continuously being agitated. After 24 hours the vacuum was released. 2-Ethylhexanol (29.97 Kg) was then added to the reactor and the vacuum was restored. The reaction was allowed to continue under the same conditions (60° C., 10 torr abs) for 4 more hours. At which time, KOH (645.58 g) was dissolved in 90% ethanol/water (5000 mL, 90% EtOH by volume) and added to the reactor to quench the acid. The solution was then allowed to cool for approximately 30 minutes. The contents of the reactor were then pumped through a 1 micron (μ) filter into an accumulator to filter out the salts. Water was then added to the accumulator to wash the oil. The two liquid phases were thoroughly mixed together for approximately 1 hour. The solution was then allowed to phase separate for approximately 30 minutes. The water layer was drained and disposed of. The organic layer was again pumped through a 1μ filter back into the reactor. The reactor was heated to 60° C. in vacuo (10 torr abs) until all ethanol and water ceased to distill from solution. The reactor was then heated to 100° C. in vacuo (10 torr abs) and that temperature was maintained until the 2-ethylhexanol ceased to distill from solution. The remaining material was then distilled using a Myers 15 Centrifugal Distillation still at 200° C. under an absolute pressure of approximately 12 microns (0.012 torr) to remove all monoester material leaving behind estolides (Ex. 1). Certain data are reported below in Tables 1 and 8.
Example 2
The acid catalyst reaction was conducted in a 50 gallon Pfaudler RT-Series glass-lined reactor. Oleic acid (50 Kg, OL 700, Twin Rivers) and whole cut coconut fatty acid (18.754 Kg, TRC 110, Twin Rivers) were added to the reactor with 70% perchloric acid (1145 mL, Aldrich Cat#244252) and heated to 60° C. in vacuo (10 torr abs) for 24 hrs while continuously being agitated. After 24 hours the vacuum was released. 2-Ethylhexanol (34.58 Kg) was then added to the reactor and the vacuum was restored. The reaction was allowed to continue under the same conditions (60° C., 10 torr abs) for 4 more hours. At which time, KOH (744.9 g) was dissolved in 90% ethanol/water (5000 mL, 90% EtOH by volume) and added to the reactor to quench the acid. The solution was then allowed to cool for approximately 30 minutes. The contents of the reactor were then pumped through a 11.1 filter into an accumulator to filter out the salts. Water was then added to the accumulator to wash the oil. The two liquid phases were thoroughly mixed together for approximately 1 hour. The solution was then allowed to phase separate for approximately 30 minutes. The water layer was drained and disposed of. The organic layer was again pumped through a 1μ filter back into the reactor. The reactor was heated to 60° C. in vacuo (10 torr abs) until all ethanol and water ceased to distill from solution. The reactor was then heated to 100° C. in vacuo (10 torr abs) and that temperature was maintained until the 2-ethylhexanol ceased to distill from solution. The remaining material was then distilled using a Myers 15 Centrifugal Distillation still at 200° C. under an absolute pressure of approximately 12 microns (0.012 torr) to remove all monoester material leaving behind estolides (Ex. 2). Certain data are reported below in Tables 2 and 7.
Example 3
The estolides produced in Example 1 (Ex. 1) were subjected to distillation conditions in a Myers 15 Centrifugal Distillation still at 300° C. under an absolute pressure of approximately 12 microns (0.012 torr). This resulted in a primary distillate having a lower EN average (Ex. 3A), and a distillation residue having a higher EN average (Ex. 3B). Certain data are reported below in Tables 1 and 8.












TABLE 1









Pour
Iodine



Estolide

Point
Value



Base Stock
EN
(° C.)
(cg/g)









Ex. 3A
1.35
−32
31.5



Ex. 1
2.34
−40
22.4



Ex. 3B
4.43
−40
13.8










Example 4
Estolides produced in Example 2 (Ex. 2) were subjected to distillation conditions in a Myers 15 Centrifugal Distillation still at 300° C. under an absolute pressure of approximately 12 microns (0.012 torr). This resulted in a primary distillate having a lower EN average (Ex. 4A), and a distillation residue having a higher EN average (Ex. 4B). Certain data are reported below in Tables 2 and 7.












TABLE 2









Pour
Iodine



Estolide

Point
Value



Base Stock
EN
(° C.)
(cg/g)





















Ex. 4A
1.31
−30
13.8



Ex. 2
1.82
−33
13.2



Ex. 4B
3.22
−36
9.0










Example 5
Estolides produced by the method set forth in Example 1 were subjected to distillation conditions (ASTM D-6352) at 1 atm (atmosphere) over the temperature range of about 0° C. to about 710° C., resulting in 10 different estolide cuts recovered at increasing temperatures The amount of material distilled from the sample in each cut and the temperature at which each cut distilled (and recovered) are reported below in Table 3:










TABLE 3







Cut (% of total)
Temp. (° C.)


















1
(1%)
416.4


2
(1%)
418.1


3
(3%)
420.7


4
(20%)
536.4


5
(25%)
553.6


6
(25%)
618.6


7
(20%)
665.7


8
(3%)
687.6


9
(1%)
700.6


10
(1%)
709.1









Example 6
Estolides made according to the method of Example 2 were subjected to distillation conditions (ASTM D-6352) at 1 atm over the temperature range of about 0° C. to about 730° C., which resulted in 10 different estolide cuts. The amount of each cut and the temperature at which each cut was recovered are reported in Table 4.










TABLE 4







Cut (% of total)
Temp. (° C.)


















1
(1%)
417.7


2
(1%)
420.2


3
(3%)
472.0


4
(5%)
509.7


5
(15%)
533.7


6
(25%)
583.4


7
(25%)
636.4


8
(5%)
655.4


9
(5%)
727.0


10
(15%)
>727.0









Example 7
Estolide base oil 4B (from Example 4) was subjected to distillation conditions (ASTM D-6352) at 1 atm over the temperature range of about 0° C. to about 730° C., which resulted in 9 different estolide cuts. The amount of each cut and the temperature at which each cut was recovered are reported in Table 5a.










TABLE 5a







Cut (% of total)
Temp. (° C.)


















1
(1%)
432.3


2
(1%)
444.0


3
(3%)
469.6


4
(5%)
521.4


5
(15%)
585.4


6
(25%)
617.1


7
(25%)
675.1


8
(5%)
729.9


9
(20%)
>729.9









Example 8
Estolides were made according to the method set forth in Example 1, except that the 2-ethylhexanol esterifying alcohol used in Example 1 was replaced with various other alcohols. Alcohols used for esterifiction include those identified in Table 5b below. The properties of the resulting estolides are set forth in Table 9.








TABLE 5b





Alcohol
Structure







Jarcol TM I-18CG
iso-octadecanol


Jarcol TM I-12
2-butyloctanol


Jarcol TM I-20 
2-octyldodecanol


Jarcol TM I-16
2-hexyldecanol


Jarcol TM 85BJ
cis-9-octadecen-1-ol


 


Fineoxocol ® 180






 


Jarcol TM I-18T
2-octyldecanol









Example 9
Estolides were made according to the method set forth in Example 2, except the 2-ethylhexanol esterifying alcohol was replaced with isobutanol. The properties of the resulting estolides are set forth in Table 9.
Example 10
Estolides of Formula I, II, and III are prepared according to the method set forth in Examples 1 and 2, except that the 2-ethylhexanol esterifying alcohol is replaced with various other alcohols. Alcohols to be used for esterifictaion include those identified in Table 6 below. Esterifying alcohols to be used, including those listed below, may be saturated or unsaturated, and branched or unbranched, or substituted with one or more alkyl groups selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, isohexyl, and the like, to form a branched or unbranched residue at the R2 position. Examples of combinations of esterifying alcohols and R2 Substituents are set forth below in Table 6:










TABLE 6







Alcohol
R2 Substituents









C1 alkanol
methyl



C2 alkanol
ethyl



C3 alkanol
n-propyl, isopropyl



C4 alkanol
n-butyl, isobutyl, sec-butyl



C5 alkanol
n-pentyl, isopentyl neopentyl



C6 alkanol
n-hexyl, 2-methyl pentyl, 3-




methyl pentyl, 2,2-dimethyl




butyl, 2,3-dimethyl butyl



C7 alkanol
n-heptyl and other structural




isomers



C8 alkanol
n-octyl and other structural




isomers



C9 alkanol
n-nonyl and other structural




isomers



C10 alkanol
n-decanyl and other structural




isomers



C11 alkanol
n-undecanyl and other structural




isomers



C12 alkanol
n-dodecanyl and other structural




isomers



C13 alkanol
n-tridecanyl and other structural




isomers



C14 alkanol
n-tetradecanyl and other




structural isomers



C15 alkanol
n-pentadecanyl and other




structural isomers



C16 alkanol
n-hexadecanyl and other




structural isomers



C17 alkanol
n-heptadecanyl and other




structural isomers



C18 alkanol
n-octadecanyl and other




structural isomers



C19 alkanol
n-nonadecanyl and other




structural isomers



C20 alkanol
n-icosanyl and other structural




isomers



C21 alkanol
n-heneicosanyl and other




structural isomers



C22 alkanol
n-docosanyl and other structural




isomers






















TABLE 7







ASTM





PROPERTY
ADDITIVES
METHOD
Ex. 4A
Ex. 2
Ex. 4B







Color
None
—
Light
Amber
Amber





Gold


Specific Gravity
None
D 4052
0.897
0.904.
0.912


(15.5° C.), g/ml


Viscosity -
None
D 445
32.5
65.4
137.3


Kinematic at


40° C., cSt


Viscosity -
None
D 445
6.8
11.3
19.9


Kinematic at


100° C., cSt


Viscosity Index
None
D 2270
175
167
167


Pour Point, ° C.
None
D 97
−30
−33
−36


Cloud Point, ° C.
None
D 2500
−30
−32
−36


Flash Point, ° C.
None
D 92
278
264
284


Fire Point, ° C.
None
D 92
300
300
320


Evaporative Loss
None
D 5800
1.9
1.4
0.32


(NOACK), wt. %


Vapor Pressure -
None
D 5191
≈0
≈0
≈0


Reid (RVP), psi





















TABLE 8







ASTM





PROPERTY
ADDITIVES
METHOD
Ex. 3A
Ex. 1
Ex. 3B







Color
None
—
Light
Amber
Amber





Gold


Specific Gravity
None
D 4052
0.897
0.906
0.917


(15.5° C.), g/ml


Viscosity -
None
D 445
40.9
91.2
211.6


Kinematic at


40° C., cSt


Viscosity -
None
D 445
8.0
14.8
27.8


Kinematic at


100° C., cSt


Viscosity Index
None
D 2270
172
170
169


Pour Point, ° C.
None
D 97
−32
−40
−40


Cloud Point, ° C.
None
D 2500
−32
−33
−40


Rash Point, ° C.
None
D 92
278
286
306


Fire Point, ° C.
None
D 92
300
302
316


Evaporative Loss
None
D 5800
1.4
0.8
0.3


(NOACK), wt. %


Vapor Pressure -
None
D 5191
≈0
≈0
≈0


Reid (RVP), psi























TABLE 9







Estimated
Pour
Cloud





Example

EN
Pt.
Pt.
Visc. @
Visc. @
Visc.


#
Alcohol
(approx.)
° C.
° C.
40° C.
100° C.
Index






















8
Jarcol TM I-18CG
2.0-2.6
−15
−13
103.4
16.6
174


8
Jarcol TM I-12
2.0-2.6
−39
−40
110.9
16.9
166


8
Jarcol TM I-20
2.0-2.6
−42
<−42
125.2
18.5
166


8
Jarcol TM I-16
2.0-2.6
−51
<−51
79.7
13.2
168


8
Jarcol TM 85BJ
2.0-2.6
−15
−6
123.8
19.5
179


8
Fineoxocol ®
2.0-2.6
−39
−41
174.2
21.1
143



180


8
Jarcol TM I-18T
2.0-2.6
−42
<−42
130.8
19.2
167


8
Isobutanol
2.0-2.6
−36
−36
74.1
12.6
170


9
Isobutanol
1.5-2.2
−36
−36
59.5
10.6
170









Example 11
Saturated and unsaturated estolides having varying acid values were subjected to several corrosion and deposit tests. These tests included the High Temperature Corrosion Bench Test (HTCBT) for several metals, the ASTM D130 corrosion test, and the MHT-4 TEOST (ASTM D7097) test for correlating piston deposits. The estolides tested having higher acid values (0.67 mg KOH/g) were produced using the method set forth in Examples 1 and 4 for producing Ex. 1 and Ex. 4A (Ex.1* and Ex.4A* below). The estolides tested having lower acid values (0.08 mg KOH/g) were produced using the method set forth in Examples 1 and 4 for producing Ex. 1 and Ex. 4A except the crude free-acid estolide was worked up and purified prior to esterification with BF3.OET2 (0.15 equiv.; reacted with estolide and 2-EH in Dean Stark trap at 80° C. in vacuo (10 torr abs) for 12 hrs while continuously being agitated; crude reaction product washed 4×H20; excess 2-EH removed by heating washed reaction product to 140° C. in vacuo (10 torr abs) for 1 hr) (Ex.4A# below). Estolides having an IV of 0 were hydrogenated via 10 wt. % palladium embedded on carbon at 75° C. for 3 hours under a pressurized hydrogen atmosphere (200 psig) (Ex.4A*H and Ex.4A#H below) The corrosion and deposit tests were performed with a DexosTM additive package. Results were compared against a mineral oil standard:














TABLE 10








Ex. 1*
Ex. 4A*
Ex. 4A*H
Ex. 4A#
Ex. 4A#H



Standard
Estolide
Estolide
Estolide
Estolide
Estolide






















Acid Value
—
~0.7
0.67
0.67
0.08
0.08


(mg KOH/g)


Iodine Value
—
~45
16
0
16
0


(IV)


HTCBT Cu
13
739
279
60
9.3
13.6


HTCBT Pd
177
11,639
1,115
804
493
243


HTCBT Sn
0
0
0
0
0
0


ASTM D130
1A
4B
3A
1B
1A
1A


MHT-4
18
61
70
48
12
9.3









Example 12
“Ready” and “ultimate” biodegradability of the estolide produced in Ex. 1 was tested according to standard OECD procedures. Results of the OECD biodegradability studies are set forth below in Table 11:










TABLE 11







301D 28-Day
302D Assay



(% degraded)
(% degraded)




















Canola Oil
86.9
78.9



Ex. 1
64.0
70.9



Base Stock










Example 13
The Ex. 1 estolide base stock from Example 1 was tested under OECD 203 for Acute Aquatic Toxicity. The tests showed that the estolides are nontoxic, as no deaths were reported for concentration ranges of 5,000 mg/L and 50,000 mg/L.
Example 14
Estolide base oils were produced according to methods set forth in Examples 1 through 4 for Ex. 1, Ex. 2, Ex. 3A, Ex. 3B, Ex. 4A, and Ex. 4B (Ex. 1♦, Ex. 2♦, Ex. 3A♦, Ex. 3B♦, Ex. 4A♦, and Ex. 4B♦, respectively, below). These estolide base oils were subjected to one or more of the tests set forth in ASTM D6871-03 (Reapproved 2008). The results for each of those tests are as follows:
















TABLE 12







ASTM
ASTM
Ex. 1♦
Ex. 2♦
Ex. 3A♦
Ex. 3B♦
Ex. 4A♦
Ex. 4B♦



Standard
Limit
Estolide
Estolide
Estolide
Estolide
Estolide
Estolide
























Fire Pt.
D 92
300
302
300
300
316
300
320


(° C.)

(min.)


Flash Pt.
D 92
275
286
264
278
306
278
284


(° C.)

(min.)


Pour Pt.
D 97
−10
−40
−33
−32
−40
−30
−36


(° C.)

(max.)


Visc. @ 100° C.
D 445
 15
14.8
11.3
8.0
27.8
6.8
19.9


(cSt)

(max.)


Visc. @ 40° C.
D 445
 50
91.2
65.4
40.9
211.6
32.5
137.3


(cSt)

(max.)









Example 15
Estolides were prepared according to the methods set forth for Examples 4A and 4A#H. The physical and electrical properties of those estolides were compared to those reported for Envirotemp® FR3TM (Cooper Technologies, Houston, Tex.) and BIOTEMP® (ABB Inc., Alamo, Tenn.). The results of those tests are set forth in Table 13.












TABLE 13






ASTM
Envirotemp ®





Property
Standard
FR3 TM*
BIOTEMP ®**
Ex. 4A
Ex. 4A#H







Dielectric strength, 25° C.
D877
47 kV
45 kV
46 kV
29 kV



D1816
56 kV
65 kV
33 kV
29 kV




(0.08′′ gap)
(0.08′′ gap)
(0.04′′ gap)
(0.04′′ gap)


Dielectric constant, 25° C.
D 924
3.2
3.2
3.3
3.4


Specific gravity, g/ml, 25° C.
D 1298
0.92
0.91
0.90
0.90





(15° C.)


Fire Pt. (° C.)
D 92
360
360
300
—


Flash Pt. (° C.)
D 92
330
330
278
—


Pour Pt. (° C.)
D 97
−21
−15 to −25
−30
−15


Visc. @ 100° C. (cSt)
D 445
8
10
6.8
6.8


Visc. @ 40° C. (cSt)
D 445
33
45
32.5
33.3





*All product properties reported by Envirotemp ® FR3 TM Product Information Bulletin 00092, available at http://www.nttworldwide.com/docs/fr3brochure.pdf, last visited on Feb. 27, 2012.


**All product properties reported by BIOTEMP ® Descriptive Bulletin 47-1050, available at http://www.nttworldwide.com/docs/BIOTEMP-ABB.pdf, last visited Feb. 27, 2012.






Example 16
Estolides are prepared according to the methods set forth for Examples 3A and 4A. The estolides are then subjected treatment with Fuller's earth and filtered. The electrical and physical properties of the resulting estolides are then individually tested, including one or more of ASTM Method D1500, ASTM Method D877 (disk electrodes, kV) and D1816 (VDE electrodes, kV), ASTM Method D3300, ASTM method D924, ASTM Method D2300, ASTM Method D1275, ASTM Method D974, ASTM Method D4059, ASTM Method D1533, ASTM Method D1298, ASTM Method D97-96a, ASTM Method D2500, ASTM Method D445-97, ASTM Method D2270-93 (Reapproved 1998), ASTM Method D4052, ASTM Method D92, ASTM Method D5800, ASTM Method D5191, or acute aqueous toxicity is measured by Organization of Economic Cooperation and Development (OECD) 203.

## Claims

1. A method of dissipating heat away from a device, comprising contacting at least a portion of the device with a composition having an EN selected from an integer or fraction of an integer that is equal to or less than 1.5, wherein the EN is the average number of estolide linkages in compounds according to Formula I, and wherein the composition comprises at least one estolide compound of Formula I:



wherein
x is, independently for each occurrence, an integer selected from 0 to 20;
y is, independently for each occurrence, an integer selected from 0 to 20;
n is an integer equal to or greater than 0;
R1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched,
wherein each fatty acid chain residue of said at least one estolide compound is independently optionally substituted, and
wherein said composition has a total acid number equal to or less than 0.1 mg KOH/g.

2. The method according to claim 1, wherein
x is, independently for each occurrence, an integer selected from 1 to 10;
y is, independently for each occurrence, an integer selected from 1 to 10;
n is an integer selected from 0 to 8;
R1 is an optionally substituted C1 to C22 alkyl that is saturated or unsaturated, and branched or unbranched; and
R2 is an optionally substituted C1 to C22 alkyl that is saturated or unsaturated, and branched or unbranched,
wherein each fatty acid chain residue is unsubstituted.

3. The method according to claim 2, wherein
x+y is, independently for each fatty acid chain residue, an integer selected from 13 to 15; and
n is an integer selected from 0 to 6.

4. The method according to claim 3, wherein x is, independently for each occurrence, an integer selected from 7 and 8.

5. The method according to claim 3, wherein y is, independently for each occurrence, an integer selected from 7 and 8.

6. The method according to claim 3, wherein x+y is 15 for at least one fatty acid chain residue.

7. The method according to claim 1, wherein R2 is an unsubstituted alkyl that is saturated or unsaturated, and branched or unbranched.

8. The method according to claim 1, wherein R2 is a branched or unbranched C1 to C20 alkyl that is saturated or unsaturated.

9. The method according to claim 8, wherein R2 is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecanyl, dodecanyl, tridecanyl, tetradecanyl, pentadecanyl, hexadecanyl, heptadecanyl, octadecanyl, nonadecanyl, and icosanyl, which are saturated or unsaturated and branched or unbranched.

10. The method according to claim 1, wherein R2 is selected from C6 to C12 alkyl.

11. The method according to claim 1, wherein R1 is a branched or unbranched C1 to C20 alkyl that is saturated or unsaturated.

12. The method according to claim 11, wherein R1 is selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decanyl, undecanyl, dodecanyl, tridecanyl, tetradecanyl, pentadecanyl, hexadecanyl, heptadecanyl, octadecanyl, nonadecanyl, and icosanyl, which are saturated or unsaturated and branched or unbranched.

13. The method according to claim 1, wherein R1 is selected from unsubstituted C7 to C17 alkyl that is unbranched and saturated or unsaturated.

14. The method according to claim 13, wherein R1 is saturated.

15. The method according to claim 1, wherein said composition has a kinematic viscosity equal to or less than 45 cSt when measured at 40° C.

16. The method according to claim 15, wherein said composition has a pour point equal to or lower than −25° C.

17. The method according to claim 1, wherein said composition further comprises at least one additive selected from one or more of an antioxidant, antimicrobial agent, a cold flow modifier, a pour point modifier, a metal chelating agent, or a metal deactivator.

18. The method according to claim 1, wherein said composition has a fire point of greater than or equal to 300° C.

19. The method according to claim 1, wherein said composition has a flash point of greater than or equal to 275° C.

20. The method according to claim 1, wherein said composition has an electrical conductivity of less than or equal to 5 pS/M at 25° C.

21. The method according to claim 1, wherein said composition has a color of less than or equal to 1 when measured according to ASTM Method D1500.

22. The method according to claim 1, wherein said composition has a dielectric breakdown voltage under impulse conditions (25° C., needle negative to sphere grounded, 1 in.) of greater than or equal to 130 kV.

23. The method according to claim 17, wherein the at least one additive comprises an antioxidant selected from BHT, BHA, TBHQ, DBPC, THBP, an alkylated diphenylamine, vitamin E, and ascorbyl palmitate.

24. The method according to claim 1, wherein the device comprises at least one transformer.

25. The method according to claim 24, wherein said at least one transformer comprises a housing and a core/coil assembly, wherein the core/coil assembly is positioned in the housing and wherein the composition surrounds at least a portion of the core/coil assembly.

26. The method according to claim 1, wherein said device comprises a fluid-filled transmission cable.

27. The method according to claim 1, wherein said composition further comprises at least one additive selected from one or more of a polyalphaolefin, a synthetic ester, a polyalkylene glycol, a mineral oil, a vegetable oil, an animal-based oil, a monoglyceride, a diglyceride, a triglyceride, or a fatty-acid ester.